Amalgamated Bank Buys New Stake in Astrana Health, Inc. (NASDAQ:ASTH)

Amalgamated Bank purchased a new stake in shares of Astrana Health, Inc. (NASDAQ:ASTH) during the third quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor purchased 12,303 shares of the company’s stock, valued at approximately $713,000.

A number of other hedge funds have also bought and sold shares of the stock. GAMMA Investing LLC purchased a new stake in Astrana Health during the third quarter worth $34,000. Nisa Investment Advisors LLC acquired a new stake in Astrana Health during the third quarter worth about $35,000. Central Pacific Bank Trust Division acquired a new stake in shares of Astrana Health during the third quarter valued at about $160,000. Everence Capital Management Inc. acquired a new stake in shares of Astrana Health during the third quarter valued at about $272,000. Finally, Granite Bay Wealth Management LLC acquired a new position in shares of Astrana Health in the third quarter valued at approximately $290,000. Institutional investors and hedge funds own 52.77% of the company’s stock.

Analyst Upgrades and Downgrades

ASTH has been the subject of a number of recent research reports. TD Cowen assumed coverage on shares of Astrana Health in a research note on Monday, October 14th. They issued a “buy” rating and a $66.00 price target for the company. Stifel Nicolaus boosted their target price on Astrana Health from $48.00 to $60.00 and gave the stock a “buy” rating in a research report on Thursday, August 1st. Truist Financial upped their price target on Astrana Health from $50.00 to $59.00 and gave the stock a “buy” rating in a report on Friday, August 9th. BTIG Research upped their target price on Astrana Health from $60.00 to $70.00 and gave the company a “buy” rating in a research note on Thursday, October 3rd. Finally, Robert W. Baird upped their target price on Astrana Health from $67.00 to $86.00 and gave the company an “outperform” rating in a research note on Wednesday. One investment analyst has rated the stock with a hold rating, six have issued a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of “Buy” and an average price target of $65.17.

Astrana Health Trading Down 2.6 %

Shares of NASDAQ:ASTH opened at $40.81 on Friday. The firm has a fifty day moving average of $55.04 and a two-hundred day moving average of $47.66. The firm has a market capitalization of $2.30 billion, a P/E ratio of 31.39, a price-to-earnings-growth ratio of 1.96 and a beta of 1.24. Astrana Health, Inc. has a 12-month low of $32.04 and a 12-month high of $63.20. The company has a quick ratio of 1.84, a current ratio of 1.91 and a debt-to-equity ratio of 0.60.

Astrana Health (NASDAQ:ASTH) last released its earnings results on Thursday, November 7th. The company reported $0.33 earnings per share for the quarter, hitting analysts’ consensus estimates of $0.33. Astrana Health had a net margin of 3.63% and a return on equity of 9.37%. The firm had revenue of $478.71 million during the quarter, compared to analyst estimates of $462.01 million. During the same quarter in the previous year, the business earned $0.47 EPS. On average, equities analysts expect that Astrana Health, Inc. will post 1.16 EPS for the current fiscal year.

Astrana Health Profile

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.